AngioScore

company

About

AngioScore develops scoring balloon catheters to treat cardiovascular and peripheral artery diseases.

  • 51 - 100

Details

Last Funding Type
Series E
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets.

Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$75M
AngioScore has raised a total of $75M in funding over 2 rounds. Their latest funding was raised on Oct 9, 2007 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 9, 2007 Series E $30M 1 Detail
Apr 11, 2006 Series D $30M 1 Detail
Aug 23, 2004 Series B $15M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
AngioScore is funded by 1 investors. Innomed Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Innomed Ventures Series E